EPIC (Emerging and Pandemic Infections Consortium)

The Emerging and Pandemic Infections Consortium (EPIC) harnesses the full potential of Toronto’s diverse community, at U of T and its partner hospitals, of clinicians, scientists, engineers, and public health and policy-focused infectious disease experts to converge on innovative approaches that ensure future emerging infections do not wreak devastation. Anchored by U of T’s Infectious Disease Laboratories (IDL), Toronto’s only Combined Containment Level 3 (C-CL3) unit for the study of high-risk human pathogens, as well as the CL2+ aerosol containment facility and Biobank, EPIC’s virtual research and training ecosystem aims to be the leading initiative on infectious disease research and training from discovery to policy, a magnet for world-leading talent, and an authority on infectious disease-focused education and science-based advocacy.